Independent research tool — not a government agency. Official notices govern.Refreshed
OpenResearch announcementOpportunity PAR-24-296

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

National Institutes of Health · Department of Health and Human Services

At a glance

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) is an open federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). Applications are due December 3, 2026. Applicant types listed as eligible include others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.113 (Environmental Health) and 16 other listings.

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Oct 15, 2024Posted
  2. Dec 3, 2026Application deadlinenext date
  3. Jan 8, 2027Archived
Posted
Oct 15, 2024
Close date
Dec 3, 2026
Archive date
Jan 8, 2027
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
Not specified
Expected awards
Not specified
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary

Typical awards for this program (SAM.gov listing for ALN 93.113, not this notice): Range: $2,500 to $6,747,780 Average: $444,487

Who can apply

  • Others (see notice)

Additional information on eligibility (from the notice)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-.The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Additional information from the agency ↗

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

How to apply

0 of 8 done · progress saved in this browser

Assistance Listings

What is an ALN?

Reported obligations under ALN 93.113

Historical data · not a prediction
FY24$446M
FY25$466M
FY26$40.3M est.
Source: SAM.gov Assistance Listing 93.113. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

National Institutes of Health
grantsinfo@nih.gov
301-402-2541

Quick answers

When is the deadline for “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)”?

According to the official notice, applications are due December 3, 2026. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)”?

The official notice lists these applicant types as eligible: Others (see notice). Additional restrictions may apply; review the full notice.

How do I apply for “Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-24-296), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.